A surivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis

Cancer Immunology Immunotherapy

Volumn 43, Issue 6, 1997, Pages 355-360

  Jerome, Keith R ^a   Kirk, Allan D ^b   Pecher, Gabriele ^c   Ferguson, Wayne W ^d,e   Finn, Olivera J ^f  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d Sentara Virginia Beach General Hospital   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Carcinoma; Glycosylation; Immunization; Lymphocyte; Tumor antigen

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUCIN; TUMOR ANTIGEN; CA 15-3 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER SURVIVAL; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; LACTATION; MASTITIS; PRIORITY JOURNAL; BREAST TUMOR; IMMUNOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATION; MASTITIS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 0030615097     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050344     Document Type: Article

References (12)

1. Agrawal B, Reddish MA, Krantz MJ, Longenecker BM (1995) Does pregnancy immunize against breast cancer? Cancer Res 55:2257
2. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the protein core of the human milk mucin. Cancer Res 47:5476
3. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61
4. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43:1072
5. Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IFC, Bast RC Jr, Finn OJ (1991) Cytotoxic T lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908
6. Jerome KR, Domenech N, Finn OJ (1993) Cytotoxic T lymphocyte clones from patients with breast and pancreatic adenocarcinoma specifically recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin cDNA. J Immunol 151:1654
7. Kalache A, Maquire A, Thompson SG (1993) Age at last full-term pregnancy and risk of breast cancer. Lancet 341:33
8. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54:2856
9. MacMahon B, Cole P, Brown J (1973) Etiology of human breast cancer: a review. J Natl Cancer Inst 50:21
10. MacMahon B, Purde M, Cramer D, Hint E (1982) Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian Republic. J Natl Cancer Inst 69:1035
11. Taswell C (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614
12. Xing PX, Tjandra JJ, Slacker SA, Teh JG, Thompson CH, McLaughlin PJ, McKenzie IFC (1989) Monoclonal antibodies reactive with mucin expessed in breast cancer. Immonol Cell Biol 67:183